HELE Quote, Financials, Valuation and Earnings

European Wax Center has a net margin of 10.48% compared to Helen Of Troy's net margin of 3.96%. Helen Of Troy's return on equity of 7.67% beat European Wax Center's return on equity of 9.76%.

Helen Of Troy has a consensus price target of $49.00, signalling upside risk potential of 93.75%. On the other hand European Wax Center has an analysts' consensus of $6.31 which suggests that it could grow by 98.51%. Given that European Wax Center has higher upside potential than Helen Of Troy, analysts believe European Wax Center is more attractive than Helen Of Troy.

Helen Of Troy has a beta of 0.912, which suggesting that the stock is 8.84% less volatile than S&P 500. In comparison European Wax Center has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Helen Of Troy has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. European Wax Center offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen Of Troy pays -- of its earnings as a dividend. European Wax Center pays out 7.54% of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Helen Of Troy quarterly revenues are $485.9M, which are larger than European Wax Center quarterly revenues of $49.7M. Helen Of Troy's net income of $50.9M is higher than European Wax Center's net income of $2M. Notably, Helen Of Troy's price-to-earnings ratio is 4.69x while European Wax Center's PE ratio is 14.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen Of Troy is 0.31x versus 0.69x for European Wax Center. Usually stocks with elevated PS ratios are considered overvalued.

Hims & Hers Health has a net margin of 10.48% compared to Helen Of Troy's net margin of 5.41%. Helen Of Troy's return on equity of 7.67% beat Hims & Hers Health's return on equity of 32.03%.

Helen Of Troy has a consensus price target of $49.00, signalling upside risk potential of 93.75%. On the other hand Hims & Hers Health has an analysts' consensus of $42.53 which suggests that it could grow by 1.55%. Given that Helen Of Troy has higher upside potential than Hims & Hers Health, analysts believe Helen Of Troy is more attractive than Hims & Hers Health.

Helen Of Troy has a beta of 0.912, which suggesting that the stock is 8.84% less volatile than S&P 500. In comparison Hims & Hers Health has a beta of 1.846, suggesting its more volatile than the S&P 500 by 84.575%.

Helen Of Troy has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hims & Hers Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen Of Troy pays -- of its earnings as a dividend. Hims & Hers Health pays out -- of its earnings as a dividend.

Helen Of Troy quarterly revenues are $485.9M, which are larger than Hims & Hers Health quarterly revenues of $481.1M. Helen Of Troy's net income of $50.9M is higher than Hims & Hers Health's net income of $26M. Notably, Helen Of Troy's price-to-earnings ratio is 4.69x while Hims & Hers Health's PE ratio is 77.56x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen Of Troy is 0.31x versus 6.72x for Hims & Hers Health. Usually stocks with elevated PS ratios are considered overvalued.

The Beauty Health has a net margin of 10.48% compared to Helen Of Troy's net margin of -12.37%. Helen Of Troy's return on equity of 7.67% beat The Beauty Health's return on equity of -47.95%.

Helen Of Troy has a consensus price target of $49.00, signalling upside risk potential of 93.75%. On the other hand The Beauty Health has an analysts' consensus of $1.53 which suggests that it could grow by 44.65%. Given that Helen Of Troy has higher upside potential than The Beauty Health, analysts believe Helen Of Troy is more attractive than The Beauty Health.

Helen Of Troy has a beta of 0.912, which suggesting that the stock is 8.84% less volatile than S&P 500. In comparison The Beauty Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Helen Of Troy has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen Of Troy pays -- of its earnings as a dividend. The Beauty Health pays out -- of its earnings as a dividend.

Helen Of Troy quarterly revenues are $485.9M, which are larger than The Beauty Health quarterly revenues of $83.5M. Helen Of Troy's net income of $50.9M is higher than The Beauty Health's net income of -$10.3M. Notably, Helen Of Troy's price-to-earnings ratio is 4.69x while The Beauty Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen Of Troy is 0.31x versus 0.44x for The Beauty Health. Usually stocks with elevated PS ratios are considered overvalued.